Home/Pipeline/Photosoft‑Solid Tumor

Photosoft‑Solid Tumor

Hard‑to‑Treat Solid Tumors

PreclinicalActive

Key Facts

Indication

Hard‑to‑Treat Solid Tumors

Phase

Preclinical

Status

Active

Company

About Invion

Australianion leverages its Photosoft™ PDT platform to develop targeted, low‑toxicity cancer and disease therapies.

View full company profile

Therapeutic Areas

Oncology Infectious Diseases Dental/Periodontal Ophthalmology